Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Bpc 157

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: Bpc-157, 137525-51-0, Bpc 157, Bepecin, Bpc 15, Pl-10
    Molecular Formula
    C62H98N16O22
    Molecular Weight
    1419.5  g/mol
    InChI Key
    HEEWEZGQMLZMFE-RKGINYAYSA-N
    FDA UNII
    8ED8NXK95P
    Bepecin is under investigation in clinical trial NCT02637284 (PCO-02 - Safety and Pharmacokinetics Trial).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
    2.1.2 InChI
    InChI=1S/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1
    2.1.3 InChI Key
    HEEWEZGQMLZMFE-RKGINYAYSA-N
    2.1.4 Canonical SMILES
    CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)C2CCCN2C(=O)C3CCCN3C(=O)C4CCCN4C(=O)C(CCC(=O)O)NC(=O)CN
    2.1.5 Isomeric SMILES
    C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)CN
    2.2 Other Identifiers
    2.2.1 UNII
    8ED8NXK95P
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Booly Protection Compound 15

    2. Bpc 15

    3. Bpc 157

    4. Bpc-15

    5. Bpc-157

    2.3.2 Depositor-Supplied Synonyms

    1. Bpc-157

    2. 137525-51-0

    3. Bpc 157

    4. Bepecin

    5. Bpc 15

    6. Pl-10

    7. 8ed8nxk95p

    8. Booly Protection Compound 15

    9. Pld-116

    10. Pl-14736

    11. Gly-glu-pro-pro-pro-gly-lys-pro-ala-asp-asp-ala-gly-leu-val

    12. Bpc157

    13. Bpc15

    14. Unii-8ed8nxk95p

    15. Bpc-15

    16. Chembl4297358

    17. Ex-a4283

    18. Mfcd06407962

    19. Db11882

    20. Bs-14984

    21. D84081

    22. Q27270252

    23. Gastric Juice Peptide Fragment Trifluoroacetate (bpc 157) (h-gly-l-glu-l-pro-l-pro-l-pro-gly-l-lys-l-pro-l-ala-l-asp-l-asp-l-ala-gly-l-leu-l-val-oh)

    24. L-valine, Glycyl-l-.alpha.-glutamyl-l-prolyl-l-prolyl-l-prolylglycyl-l-lysyl-l-prolyl-l-alanyl-l-.alpha.-aspartyl-l-.alpha.-aspartyl-l-alanylglycyl-l-leucyl-

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 1419.5 g/mol
    Molecular Formula C62H98N16O22
    XLogP3-9
    Hydrogen Bond Donor Count16
    Hydrogen Bond Acceptor Count24
    Rotatable Bond Count39
    Exact Mass1418.70415882 g/mol
    Monoisotopic Mass1418.70415882 g/mol
    Topological Polar Surface Area574 Ų
    Heavy Atom Count100
    Formal Charge0
    Complexity3040
    Isotope Atom Count0
    Defined Atom Stereocenter Count12
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Anti-Ulcer Agents

    Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)